146 filings
Page 6 of 8
8-K
bnnvyahq7l8e
28 Jul 15
Egalet Announces Pricing of Public Offering of Common Stock
12:00am
8-K
fge6 yhzbpndb
28 Jul 15
Other Events
12:00am
8-K
82jxa0u5 18zh
8 Jul 15
Regulation FD Disclosure
12:00am
8-K
pse4vjkfv
2 Jul 15
Entry into a Material Definitive Agreement
12:00am
8-K
ezxeba xi2h
1 Jul 15
Egalet to Present at Upcoming Conferences This Summer
12:00am
8-K
gpeudf640usryzz
30 Jun 15
Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002
12:00am
8-K
t4yoyxy2pg 7iz
29 Jun 15
Egalet Announces Positive Top-Line Results from Intranasal Human Abuse Liability Study of Abuse-Deterrent Morphine, Egalet-001
12:00am
8-K
is0e45w
25 Jun 15
Other Events
12:00am
8-K
lbyqmuuydom61eadv5y4
19 Jun 15
Changes in Registrant's Certifying Accountant
12:00am
8-K
gu9rm18685z
16 Jun 15
Egalet Corporation Appoints Timothy P. Walbert as Chairman of Board of Directors
12:00am
8-K
kc4x4s83yo ui9
10 Jun 15
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
51pb217
4 Jun 15
Other Events
12:00am
8-K
unwrp9ho5gl
19 May 15
Egalet Announces Issuance of U.S. Patents Covering Guardian™ Technology and Product Candidates
12:00am
8-K
23iekmw
7 May 15
Egalet Reports First Quarter 2015 Financial Results and Provides Business Update
12:00am
8-K
t63xtegsm7655648zcm9
7 May 15
Regulation FD Disclosure
12:00am
8-K
rwli ypmf
14 Apr 15
Egalet Appoints Nicholas Nicolaides, Ph.D. and John Osborn to Board of Directors
12:00am
8-K
j8gk9 p3rfdb1ml
8 Apr 15
Egalet Announces Closing of $60 Million Offering of Convertible Senior Notes Due 2020
12:00am
8-K
eo5bt4dphk4kt3 5bl
6 Apr 15
Other Events
12:00am
8-K
sqe7cb3k9n
2 Apr 15
Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020
12:00am
8-K
8o90gazhu9ztca
2 Apr 15
Regulation FD Disclosure
12:00am